Search For "lancet"
India calls for a waiver of WTO agreement related to COVID-19 prevention:
Updated : 5 years, 1 month ago IST
New Delhi [India], February 20 (ANI): India and South Africa have called for an urgent waiver of the World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) on intellectual property related to COVID-19 prevention, containment, or treatment, s
Read More
Top medical journal calls for three urgent steps against COVID-19
Updated : 5 years, 1 month ago IST
New Delhi [India], February 20 (ANI): In an analysis, the Lancet COVID-19 Commission has called for three urgent actions in the COVID-19 response.
Read More
New study examines addiction medicine treatment
Updated : 5 years, 1 month ago IST
Washington [US], February 5 (ANI): An assessment published this week in the journal The Lancet HIV provides new insight about an initiative to integrate treatment of opioid use disorder along with HIV in Vietnam.
Read More
EU top diplomat hopes Russia's Sputnik V vaccine to be certified in Europe
Updated : 5 years, 1 month ago IST
Brussels [Belgium], February 5 (ANI/Sputnik): The European Union's high representative for the foreign policy, Josep Borrell, said Friday he was hoping the EU medicines watchdog would be able to certify Russia's Sputnik V vaccine against the coronavirus, following the recent article in The L
Read More
Russia's Sputnik V COVID-19 vaccine 91.6 per cent effective: Lancet
Updated : 5 years, 1 month ago IST
Moscow [Russia], February 2 (ANI): Russian's Sputnik V is 91.6 per cent effective at protecting people from COVID-19, according to the result of an interim analysis of the phase 3 trials published by the journal Lancet on Tuesday.
Read More
COVAXIN shows high safety, immunogenicity during phase 1 clinical trial: L
Updated : 5 years, 2 months ago IST
New Delhi [India], January 22 (ANI): In a remarkable finding, India's indigenous Covid-19 vaccine--COVAXIN developed by the Bharat Biotech and Indian Council of Medical Research (ICMR) has shown high safety and immunogenicity during the phase 1 clinical trial, according to the findings of th
Read More
Watch Your Health and Madhavbaug launch New Age Phygital Healthcare Platfo
Updated : 5 years, 3 months ago IST
Mumbai (Maharashtra) [India], December 22 (ANI/BusinessWire India): Watch Your Health, one of the leading tech startup companies with more than 10 lakh serviced clients served digitally across India in association with Madhavbaug, a leading chain of 255 cardiac care clinics and 2 hospitals w
Read More
UK's Oxford vaccine phase-2 trial indicates strong results in older adults
Updated : 5 years, 4 months ago IST
New Delhi [India], November 19 (ANI): In a major development, UK's Covid-19 vaccine has shown similar strong immune response in healthy older adults -aged 56 years and above- to those seen in people between 18 to 55 years, according to findings from a phase-2 trial.
Read More
Arogya World recognises 14 Indian Companies as Healthy Workplaces in India
Updated : 5 years, 4 months ago IST
Bangalore (Karnataka) [India], November 3 (ANI/BusinessWire India): Arogya World today recognised 14 companies, across India as "Healthy Workplaces for 2020", bringing the total number of Healthy Workplaces that Arogya World has recognised to 145, with a total workforce of about 3.1 milli
Read More
DCGI directs Dr Reddy's lab to furnish fresh protocol to seek approval for
Updated : 5 years, 5 months ago IST
New Delhi [India], October 6 (ANI): In the latest development, the Drugs Controller General of India (DCGI) expert panel has directed the pharma giant Dr Reddy's Laboratories (DRL) to submit a revised protocol for performing phase 2,3 clinical trials of the Russian COVID-19 vaccine (Sputnik
Read More
Mosquito-borne viruses linked to stroke
Updated : 5 years, 6 months ago IST
Washington [US], September 18 (ANI): A deadly combination of two mosquito-borne viruses may be a trigger for stroke, suggest the findings of novel research, which was published in the journal The Lancet Neurology.
Read More
Oxford's coronavirus vaccine 'safe, immunogenic': Study
Updated : 5 years, 8 months ago IST
London [UK], July 20 (ANI): A vaccine candidate developed at the University of Oxford has shown encouraging results in early human testing and appears to be "safe well-tolerated, and immunogenic", according to a study published in The Lancet.
Read More